VentriPoint DiagnosticsVPTDF 6 Current Ratio is 0.08 as of Dec. 2025, which is 76% below its 10-year median of 0.33. GuruFocus rates VPTDF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, VentriPoint Diagnostics ranks worse than 98.36% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. VentriPoint Diagnostics's current ratio for the quarter that ended in Dec. 2025 was 0.08.
VentriPoint Diagnostics has a current ratio of 0.08. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If VentriPoint Diagnostics has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for VentriPoint Diagnostics's Current Ratio or its related term are showing as below:
VPTDF'
s Current Ratio Range Over the Past 10 Years
Min: 0.08 Med: 0.33 Max: 8.76
Current: 0.08
During the past 13 years, VentriPoint Diagnostics's highest Current Ratio was 8.76. The lowest was 0.08. And the median was 0.33.
VPTDF's Current Ratio is ranked worse than 98.36% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.485
vs VPTDF: 0.08
VentriPoint Diagnostics (OTCPK:VPTDF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
VentriPoint Diagnostics Current Ratio Related Terms
VentriPoint Diagnostics Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, VentriPoint Diagnostics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VentriPoint Diagnostics Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Current Ratio distribution charts can be found below:
* The bar in red indicates where VentriPoint Diagnostics's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VentriPoint Diagnostics (VPTDF) has a Current Ratio of 0.08 as of Dec. 2025. This is 76% below median its historical median of 0.33. Over the past decade, VentriPoint Diagnostics' Current Ratio has ranged from 0.08 to 8.76. According to the industry distribution chart, VentriPoint Diagnostics ranks #840 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 98.4%.
Is VentriPoint Diagnostics' Current Ratio too high?
VentriPoint Diagnostics' current Current Ratio of 0.08 is 76% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 8.76. The Medical Devices & Instruments industry median Current Ratio is 2.49. VentriPoint Diagnostics' value of 0.08 is 96.8% below this industry median. Based on the distribution chart, VentriPoint Diagnostics ranks #840 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VentriPoint Diagnostics has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VentriPoint Diagnostics ranks #840 out of 854 companies for Current Ratio. This places VentriPoint Diagnostics in the lower half of its industry. The industry median Current Ratio is 2.49. VentriPoint Diagnostics' value of 0.08 is 96.8% below this benchmark. Historically, VentriPoint Diagnostics' own Current Ratio has ranged from 0.08 to 8.76 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 2.49, VentriPoint Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. VentriPoint Diagnostics's current Current Ratio of 0.08 is 96.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VentriPoint Diagnostics's current Current Ratio is 0.08, which is 76% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Current Ratio of 0.08. The current Current Ratio is 0.08, which is 76% below median its 10-year median of 0.33 and 96.8% below the Medical Devices & Instruments industry median of 2.49. VentriPoint Diagnostics' overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Current Ratio is 0.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
6GF Score
Get the complete analysis for VPTDF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VPTDF has been successfully added to your 
